Early data suggest personalized neoantigen vaccines activate the immune system and sustain tumor control in some patients with kidney cancer.

A personalized neoantigen vaccine may be effective in patients with clear cell renal cell carcinoma, shared David A. Braun, ...

Researchers conducted a phase 1 trial (ClinicalTrials.gov identifier NCT02950766) at Dana-Farber Harvard Cancer Center, Boston, to evaluate a neoantigen-targeting personalized cancer vaccine in ...

Researchers have harnessed the power of artificial intelligence to design a blueprint for building a vaccine that aims to ...

Assessment of Functional Status of Human Leukocyte Antigen Class I Genes in Cancer Tissues in the Context of Personalized Neoantigen Peptide Vaccine Immunotherapy. JCO Clin Cancer Inform 9 , e2400174 ...

Advancing the battleground against cancer, this research meticulously details the development of neoantigen vaccines, a beacon of hope in personalized cancer therapy. These vaccines are custom ...

“Neoantigen vaccines are personalized cancer treatments that train the immune system to recognize and attack cancer cells,” senior study researcher Toni Choueiri, a medical oncologist at Dana ...

All nine patients showed a “successful anti-cancer immune response” after getting the vaccine. Hector Pertuz – stock.adobe.com. Within three weeks of receiving the vaccine, patients showed ...

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors. Conducted at ...

Advancing the battleground against cancer, this research meticulously details the development of neoantigen vaccines, a beacon of hope in personalized cancer therapy. These vaccines are custom ...